Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program

Pediatrics

Volumn 116, Issue 1, 2005, Pages 168-173

  Lanting, Caren I ^a   Van Tijn, David A ^b   Loeber, J Gerard ^c   Vulsma, Thomas ^b   De Vijlder, Jan J M ^b   Verkerk, Paul H ^a  

^a TNO   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Average cost; Congenital hypothyroidism; Cost effectiveness; Laboratory approach; Marginal cost; Screening; Thyroid stimulating hormone; Thyroxine; Thyroxine binding globulin

Indexed keywords

THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN; THYROXINE BINDING PROTEIN;

ARTICLE; CASE FINDING; CLINICAL EFFECTIVENESS; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSIS; HEALTH PROGRAM; HUMAN; INFANT; LABORATORY TEST; NEWBORN SCREENING; OUTCOME ASSESSMENT; POPULATION; PREVALENCE; PRIORITY JOURNAL; THYROXINE BLOOD LEVEL; BLOOD; COST; COST BENEFIT ANALYSIS; ECONOMICS; LABORATORY DIAGNOSIS; NETHERLANDS; NEWBORN; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

CONGENITAL HYPOTHYROIDISM; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FALSE POSITIVE REACTIONS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; NETHERLANDS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; THYROTROPIN; THYROXINE; THYROXINE-BINDING PROTEINS;

EID: 33644619118     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-2162     Document Type: Article

References (16)

1. Vulsma T, de Vijlder JJM. Thyroid disease in newborns, infants, and children. In: Wass JAH, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. Oxford, United Kingdom: Oxford University Press; 2002:532-544
2. Dussault JH. The anecdotical history of screening for congenital hypothyroidism. J Clin Endocrinol Metab. 1999;84:4332-4334
3. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Handleiding voor Kostenonderzoek, Methoden en Richtlijnen voor Economische Evaluaties in de Gezondheidszorg [in Dutch]. Amstelveen, Netherlands: College voor Zorgverzekeringen; 2000
4. Neuhauser D, Lewicki AM. What do we gain from the sixth stool guaiac? N Engl J Med. 1975;293:226-228
5. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford, United Kingdom: Oxford University Press; 1997
6. Léger J, Larroque J, Norton J. Influence of severity of congenital hypothyroidism and adequacy of treatment on school achievement in young adolescents: a population-based cohort study. Acta Paediatr. 2001;90:1249-1256
7. Kempers MJ, van Tijn DA, van Trotsenburg AS, de Vijlder JJ, Wiedijk BM, Vulsma T. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab. 2003;88:5851-5857
8. Moreno JC, Bikker H, Kempers MJ, et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med. 2002;347:95-102
9. Tymstra T. False positive results in screening tests: experiences of parents of children screened for congenital hypothyroidism. Fam Pract. 1986;3:92-96
10. Toublanc JE. Guidelines for neonatal screening programs for congenital hypothyroidism. Acta Paediatr Suppl. 1999;432:13-14
11. Fisher DA, Dussault JH, Foley TP, et al. Screening for congenital hypothyroidism: results of screening one million North American infants. J Pediatr. 1979;94:700-705
12. Hanna CE, Krainz PL, Skeels MR, Miyahira RS, Sesser DE, LaFranchi SH. Detection of congenital hypopituitary hypothyroidism: ten-year experience in the Northwest Regional Screening Program. J Pediatr. 1986;109:959-964
13. Fisher DA. Second International Conference on Neonatal Screening: progress report. J Pediatr. 1983;102:653-654
14. Verkerk PH. 20-year national screening for phenylketonuria in the Netherlands: National Guidance Commission PKU [in Dutch]. Ned Tijdschr Geneeskd. 1995;139:2302-2305
15. Van der Kamp HJ, Noordam K, Elvers B, van Baarle M, Otten BJ, Verkerk PH. Newborn screening for congenital adrenal hyperplasia in the Netherlands. Pediatrics. 2001;108:1320-1324
16. Thompson R, Seargeant L, Winter JS. Screening for congenital adrenal hyperplasia: distribution of 17α-hydroxyprogesterone concentrations in neonatal blood spot specimens. J Pediatr. 1989;114:400-404